Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2304

TDMS Study 05067-10 Pathology Tables

NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96
Route: GAVAGE                                                                                                     Time: 13:10:54

                                                           CORE STUDY




       Facility:  Southern Research Institute

       Chemical CAS #:   58-55-9

       Lock Date:  07/14/93

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1

NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 7            4           11            9                                     
    Natural Death                                      6            9            5            8                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                37           37           34           33                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)         (50)                                   
      Muscularis, Inflammation, Chronic                1 (2%)                                                                       
   Gallbladder                                        (46)         (48)         (47)         (49)                                   
      Inflammation, Chronic                                         1 (2%)                    1 (2%)                                
   Intestine Large, Colon                             (48)         (49)         (47)         (48)                                   
      Inflammation, Chronic                                                                   1 (2%)                                
      Polyp Inflammatory                                                         1 (2%)                                             
   Intestine Large, Cecum                             (48)         (45)         (47)         (47)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
   Intestine Small, Jejunum                           (47)         (46)         (47)         (43)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                          2 (4%)                                                          
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)                    1 (2%)                                             
      Basophilic Focus                                                           1 (2%)       1 (2%)                                
      Eosinophilic Focus                               6 (12%)      7 (14%)      5 (10%)      3 (6%)                                
      Hematopoietic Cell Proliferation                 2 (4%)       1 (2%)       1 (2%)                                             
      Hyperplasia, Focal, Lymphoid                                  1 (2%)       2 (4%)       1 (2%)                                
      Inflammation, Chronic                                         3 (6%)       5 (10%)      2 (4%)                                
      Inflammation, Focal                              1 (2%)                                 1 (2%)                                
      Mixed Cell Focus                                 2 (4%)       1 (2%)       2 (4%)       2 (4%)                                
      Necrosis, Focal                                  2 (4%)       4 (8%)       2 (4%)       1 (2%)                                
      Pigmentation, Focal                                           2 (4%)       1 (2%)                                             
      Vacuolization Cytoplasmic                        6 (12%)      8 (16%)      5 (10%)      2 (4%)                                
      Bile Duct, Cyst                                  1 (2%)                                                                       
      Centrilobular, Necrosis                          1 (2%)       1 (2%)                    1 (2%)                                
      Hepatocyte, Karyomegaly                                                    1 (2%)                                             
   Mesentery                                          (10)         (8)          (6)          (5)                                    
      Hemorrhage                                                    1 (13%)                                                         
      Inflammation, Chronic                                         1 (13%)                                                         
      Fat, Necrosis                                    8 (80%)      4 (50%)      2 (33%)      2 (40%)                               
   Pancreas                                           (50)         (49)         (49)         (49)                                   
      Inflammation, Chronic                                         1 (2%)       1 (2%)                                             
      Necrosis                                         1 (2%)                                                                       
      Acinus, Atrophy, Focal                                                     2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Duct, Cyst                                       1 (2%)                    3 (6%)                                             
   Salivary Glands                                    (50)         (49)         (50)         (50)                                   
      Fibrosis                                         1 (2%)                    1 (2%)       1 (2%)                                
      Mineralization                                                                          1 (2%)                                
      Vacuolization Cytoplasmic                                     1 (2%)       1 (2%)                                             
   Stomach, Forestomach                               (50)         (49)         (49)         (50)                                   
      Cyst                                                          1 (2%)                                                          
      Edema                                            1 (2%)       1 (2%)                                                          
      Ulcer                                                                      2 (4%)                                             
      Epithelium, Hyperplasia                          6 (12%)      6 (12%)     12 (24%)      5 (10%)                               
   Stomach, Glandular                                 (49)         (49)         (48)         (50)                                   
      Edema                                            1 (2%)                                                                       
      Erosion                                          1 (2%)       1 (2%)                    1 (2%)                                
      Inflammation, Chronic                                         1 (2%)                                                          
      Mineralization                                   4 (8%)       3 (6%)       5 (10%)      9 (18%)                               
      Glands, Degeneration, Cystic, Focal             11 (22%)      5 (10%)      4 (8%)       3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic                                                                   1 (2%)                                
   Heart                                              (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic, Focal                     2 (4%)                    1 (2%)       1 (2%)                                
      Mineralization                                                1 (2%)                    1 (2%)                                
      Thrombosis                                                                              1 (2%)                                
      Artery, Inflammation, Chronic                                 1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (49)         (50)         (50)         (49)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)       1 (2%)                    2 (4%)                                
      Cyst                                             1 (2%)                    1 (2%)                                             
      Cytoplasmic Alteration, Focal                                 1 (2%)       3 (6%)                                             
      Hematopoietic Cell Proliferation                              1 (2%)       1 (2%)                                             
      Hyperplasia, Focal                                                                      1 (2%)                                
      Hypertrophy, Focal                               1 (2%)       3 (6%)                    1 (2%)                                
   Adrenal Medulla                                    (50)         (48)         (50)         (49)                                   
      Hyperplasia                                                   1 (2%)       3 (6%)                                             
   Islets, Pancreatic                                 (50)         (49)         (49)         (49)                                   
      Hyperplasia                                                   1 (2%)       1 (2%)                                             
   Parathyroid Gland                                  (49)         (47)         (42)         (45)                                   
      Cyst                                             1 (2%)       1 (2%)       2 (5%)       2 (4%)                                
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
   Pituitary Gland                                    (49)         (45)         (50)         (48)                                   
      Angiectasis                                      3 (6%)                                 1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hemorrhage                                                                              1 (2%)                                
      Pars Distalis, Angiectasis                       1 (2%)                                                                       
      Pars Distalis, Cyst                              1 (2%)       4 (9%)       1 (2%)                                             
      Pars Distalis, Cytoplasmic Alteration, Focal     3 (6%)       1 (2%)       2 (4%)       2 (4%)                                
      Pars Distalis, Hyperplasia, Focal                4 (8%)       7 (16%)     14 (28%)      6 (13%)                               
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Degeneration, Cystic, Focal                     12 (24%)     13 (26%)     10 (20%)     15 (30%)                               
      Inflammation, Chronic, Focal                     1 (2%)                                                                       
      Follicle, Cyst                                   2 (4%)      11 (22%)      5 (10%)      7 (14%)                               
      Follicular Cell, Hyperplasia                     7 (14%)      8 (16%)      8 (16%)     11 (22%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (50)         (49)         (49)         (49)                                   
      Degeneration, Cystic                             7 (14%)      3 (6%)       1 (2%)       6 (12%)                               
      Inflammation, Chronic                            1 (2%)                                 1 (2%)                                
   Ovary                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                                                             1 (2%)                                
      Cyst                                             6 (12%)      5 (10%)      5 (10%)      9 (18%)                               
      Hemorrhage                                       1 (2%)       2 (4%)       5 (10%)      1 (2%)                                
      Inflammation, Suppurative                                                               2 (4%)                                
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)                                                                       
      Cyst                                             1 (2%)                    2 (4%)       1 (2%)                                
      Hemorrhage                                       2 (4%)       1 (2%)       1 (2%)                                             
      Hydrometra                                      20 (40%)     19 (38%)     18 (36%)     13 (26%)                               
      Inflammation, Chronic                                                      1 (2%)                                             
      Inflammation, Suppurative                                                               1 (2%)                                
      Endometrium, Hyperplasia, Cystic                48 (96%)     41 (82%)     43 (86%)     40 (80%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (49)         (50)                                   
      Depletion Cellular                                                                      1 (2%)                                
      Hyperplasia                                      4 (8%)       4 (8%)       4 (8%)       2 (4%)                                
      Myelofibrosis                                                 1 (2%)                                                          
      Necrosis                                                                   1 (2%)                                             
   Lymph Node                                         (6)          (8)          (7)          (6)                                    
      Hyperplasia                                                                1 (14%)                                            
      Iliac, Inflammation, Chronic                                               1 (14%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Inguinal, Hyperplasia, Lymphoid                                                         1 (17%)                               
      Mediastinal, Hemorrhage                          1 (17%)                                                                      
   Lymph Node, Mandibular                             (48)         (49)         (44)         (43)                                   
      Ectasia                                                                    1 (2%)                                             
      Hemorrhage                                       2 (4%)       2 (4%)       1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)       3 (6%)       1 (2%)       1 (2%)                                
   Lymph Node, Mesenteric                             (48)         (46)         (48)         (45)                                   
      Atrophy                                                                                 1 (2%)                                
      Ectasia                                          1 (2%)                                                                       
      Hemorrhage                                       2 (4%)       1 (2%)       2 (4%)                                             
      Hyperplasia, Lymphoid                            1 (2%)                    1 (2%)       1 (2%)                                
      Inflammation, Chronic                                                      1 (2%)                                             
   Spleen                                             (50)         (50)         (49)         (48)                                   
      Congestion                                       1 (2%)                                                                       
      Depletion Cellular                                                                      2 (4%)                                
      Fibrosis, Focal                                                            1 (2%)       1 (2%)                                
      Hematopoietic Cell Proliferation                13 (26%)     21 (42%)     19 (39%)     12 (25%)                               
      Hyperplasia, Lymphoid                            5 (10%)      3 (6%)       2 (4%)       4 (8%)                                
      Infarct                                                       1 (2%)                                                          
      Necrosis, Focal                                                                         1 (2%)                                
   Thymus                                             (47)         (44)         (49)         (47)                                   
      Atrophy                                          2 (4%)       3 (7%)       2 (4%)       2 (4%)                                
      Cyst                                             1 (2%)       1 (2%)                    2 (4%)                                
      Hemorrhage                                                                              1 (2%)                                
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                                                          
      Necrosis                                         1 (2%)                    1 (2%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (49)         (49)         (50)         (49)                                   
      Ectasia                                          1 (2%)       1 (2%)       2 (4%)       1 (2%)                                
      Hyperplasia                                      1 (2%)                    3 (6%)       2 (4%)                                
   Skin                                               (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic, Focal                     2 (4%)                    2 (4%)       2 (4%)                                
      Ulcer                                                                      2 (4%)                                             
      Dermis, Fibrosis                                              2 (4%)                    3 (6%)                                
      Epidermis, Hyperplasia, Focal                                              2 (4%)       1 (2%)                                
      Pinna, Ulcer                                                               1 (2%)                                             
      Subcutaneous Tissue, Edema                                    4 (8%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                           9 (18%)      6 (12%)     11 (22%)     17 (34%)                               
      Hyperostosis                                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Atrophy, Focal                                   3 (6%)       1 (2%)       2 (4%)       2 (4%)                                
      Hemorrhage                                       1 (2%)                                 1 (2%)                                
      Necrosis                                                                   2 (4%)                                             
   Spinal Cord                                        (2)          (1)          (1)          (1)                                    
      Hemorrhage, Focal                                1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Hyperplasia, Histiocytic                         2 (4%)                                                                       
      Pigmentation                                     1 (2%)                                                                       
      Thrombosis                                                                 1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                              1 (2%)       2 (4%)                                             
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                                                  1 (2%)                                             
      Mucosa, Glands, Dilatation, Focal                2 (4%)       2 (4%)                    1 (2%)                                
      Nasolacrimal Duct, Cyst                                                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (1)          (2)                                                 
      Atrophy                                          1 (100%)                                                                     
      Cornea, Inflammation, Chronic                                 1 (100%)     2 (100%)                                           
   Harderian Gland                                    (6)          (6)          (8)          (2)                                    
      Hyperplasia, Focal                                            1 (17%)                                                         
      Inflammation, Chronic, Focal                                               2 (25%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Congestion                                                                              1 (2%)                                
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Infarct                                                                    1 (2%)                                             
      Metaplasia, Focal, Osseous                                    2 (4%)       3 (6%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      7.5          25 MG/KG     75 MG/KG                                  
                                                   CONTROL      MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Nephropathy                                     25 (50%)     27 (54%)     27 (54%)     25 (50%)                               
      Thrombosis                                                                 1 (2%)                                             
      Pelvis, Dilatation                               1 (2%)                                                                       
      Renal Tubule, Accumulation, Hyaline Droplet                   3 (6%)                                                          
      Renal Tubule, Casts Protein                                                1 (2%)                                             
      Renal Tubule, Degeneration                       3 (6%)                    1 (2%)       4 (8%)                                
      Renal Tubule, Dilatation                                      1 (2%)       1 (2%)                                             
      Renal Tubule, Mineralization                     1 (2%)                                 1 (2%)                                
      Renal Tubule, Pigmentation                                                 1 (2%)       1 (2%)                                
   Urinary Bladder                                    (49)         (49)         (49)         (50)                                   
      Hyperplasia, Lymphoid                            2 (4%)       2 (4%)                    1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      15 MG/KG     50 MG/KG     150                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      5            6            4           15                                     
    Moribund Sacrifice                                 9            9            2            9                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                36           35           44           26                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (49)         (49)         (48)         (43)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
   Intestine Small, Duodenum                          (48)         (49)         (49)         (41)                                   
      Inflammation, Chronic, Focal                     1 (2%)                                                                       
      Necrosis, Focal                                                                         1 (2%)                                
   Intestine Small, Jejunum                           (48)         (47)         (47)         (41)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                                       1 (2%)                                             
   Intestine Small, Ileum                             (48)         (48)         (47)         (38)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                          1 (2%)       1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   2 (4%)                                                          
      Basophilic Focus                                              1 (2%)                    1 (2%)                                
      Clear Cell Focus                                 2 (4%)       2 (4%)       3 (6%)                                             
      Congestion                                                    1 (2%)                                                          
      Eosinophilic Focus                               6 (12%)      6 (12%)      9 (18%)                                            
      Hepatodiaphragmatic Nodule                                    1 (2%)                                                          
      Inflammation, Chronic                           24 (48%)     25 (50%)     16 (32%)      3 (6%)                                
      Mineralization, Focal                                                                   1 (2%)                                
      Mixed Cell Focus                                              1 (2%)                                                          
      Necrosis, Focal                                  5 (10%)      6 (12%)      3 (6%)       2 (4%)                                
      Vacuolization Cytoplasmic                       10 (20%)     11 (22%)      6 (12%)      1 (2%)                                
      Bile Duct, Cyst                                                            1 (2%)                                             
      Bile Duct, Hyperplasia                           1 (2%)       2 (4%)       2 (4%)                                             
      Hepatocyte, Hypertrophy                                                    1 (2%)       1 (2%)                                
      Hepatocyte, Karyomegaly                         15 (30%)     14 (28%)     12 (24%)      2 (4%)                                
   Mesentery                                          (10)         (4)          (2)                                                 
      Hemorrhage                                       2 (20%)                                                                      
      Inflammation, Chronic                            1 (10%)      1 (25%)                                                         
      Thrombosis                                       1 (10%)                                                                      
      Artery, Inflammation, Chronic                    3 (30%)      1 (25%)                                                         
      Artery, Thrombosis                               1 (10%)                                                                      
      Fat, Necrosis                                    2 (20%)      1 (25%)      1 (50%)                                            
   Pancreas                                           (50)         (49)         (49)         (50)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      15 MG/KG     50 MG/KG     150                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Acinus, Atrophy, Diffuse                                      2 (4%)                                                          
      Acinus, Atrophy, Focal                           1 (2%)                    1 (2%)       1 (2%)                                
      Artery, Hypertrophy                              1 (2%)                                                                       
      Duct, Cyst                                       1 (2%)       2 (4%)                                                          
   Salivary Glands                                    (50)         (50)         (50)         (49)                                   
      Vacuolization Cytoplasmic                                                               1 (2%)                                
   Stomach, Forestomach                               (50)         (50)         (50)         (49)                                   
      Inflammation, Chronic                            1 (2%)       3 (6%)       1 (2%)                                             
      Ulcer                                            1 (2%)       3 (6%)                                                          
      Epithelium, Hyperplasia                         14 (28%)     12 (24%)     16 (32%)     13 (27%)                               
   Stomach, Glandular                                 (50)         (49)         (49)         (43)                                   
      Edema                                                                                   1 (2%)                                
      Erosion                                                                                 1 (2%)                                
      Hyperplasia                                                                1 (2%)                                             
      Mineralization                                   1 (2%)       4 (8%)       3 (6%)       1 (2%)                                
      Glands, Degeneration, Cystic, Focal              2 (4%)       7 (14%)      1 (2%)       2 (5%)                                
   Tooth                                              (10)         (5)                                                              
      Developmental Malformation                      10 (100%)     5 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Chronic, Focal                     1 (2%)       1 (2%)                                                          
      Mineralization                                                                          1 (2%)                                
      Thrombosis                                       2 (4%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (49)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)       1 (2%)                                                          
      Cyst                                             1 (2%)                                                                       
      Cytoplasmic Alteration, Focal                    1 (2%)       1 (2%)       2 (4%)                                             
      Hyperplasia, Focal                                            1 (2%)       2 (4%)                                             
      Hypertrophy, Focal                               6 (12%)      7 (14%)      9 (18%)      7 (14%)                               
      Capsule, Hyperplasia, Focal                                   2 (4%)                    2 (4%)                                
   Adrenal Medulla                                    (49)         (50)         (49)         (49)                                   
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
   Islets, Pancreatic                                 (50)         (49)         (50)         (50)                                   
      Hyperplasia                                      4 (8%)       2 (4%)                                                          
   Parathyroid Gland                                  (48)         (49)         (49)         (46)                                   
      Cyst                                             1 (2%)       1 (2%)       2 (4%)                                             
   Pituitary Gland                                    (49)         (50)         (48)         (44)                                   
      Angiectasis                                      1 (2%)       1 (2%)                                                          
      Pars Distalis, Cyst                              2 (4%)       2 (4%)       3 (6%)       1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      15 MG/KG     50 MG/KG     150                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Cytoplasmic Alteration, Focal     2 (4%)                                                                       
      Pars Distalis, Hyperplasia, Focal                1 (2%)       3 (6%)       2 (4%)       2 (5%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Degeneration, Cystic, Focal                      6 (12%)     11 (22%)     10 (20%)     13 (26%)                               
      Follicle, Cyst                                   1 (2%)       6 (12%)      3 (6%)       2 (4%)                                
      Follicular Cell, Hyperplasia                     3 (6%)       1 (2%)       3 (6%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (49)         (50)         (50)         (50)                                   
      Granuloma Sperm                                  1 (2%)       2 (4%)                                                          
      Inflammation, Chronic                            1 (2%)                                                                       
      Spermatocele                                     1 (2%)                                                                       
   Penis                                              (1)                                                                           
      Angiectasis                                      1 (100%)                                                                     
   Preputial Gland                                    (49)         (48)         (50)         (50)                                   
      Degeneration, Cystic                            23 (47%)     31 (65%)     31 (62%)     12 (24%)                               
      Inflammation, Chronic                           10 (20%)      8 (17%)      1 (2%)       3 (6%)                                
      Inflammation, Suppurative                                                  1 (2%)       1 (2%)                                
   Prostate                                           (50)         (49)         (50)         (50)                                   
      Inflammation, Chronic                                         1 (2%)                    1 (2%)                                
      Epithelium, Hyperplasia, Focal                   1 (2%)                                                                       
   Seminal Vesicle                                    (50)         (50)         (50)         (50)                                   
      Cyst                                             1 (2%)                                                                       
      Inflammation, Chronic                                         2 (4%)                                                          
   Testes                                             (50)         (50)         (50)         (50)                                   
      Cyst                                             1 (2%)                                                                       
      Mineralization, Focal                            1 (2%)                                 1 (2%)                                
      Germinal Epithelium, Degeneration                1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (49)                                   
      Angiectasis                                      1 (2%)                                                                       
      Depletion Cellular                                                                      1 (2%)                                
      Hyperplasia                                      5 (10%)      2 (4%)                                                          
   Lymph Node                                         (5)          (6)          (5)          (3)                                    
      Bronchial, Hyperplasia, Lymphoid                                                        1 (33%)                               
      Inguinal, Hyperplasia, Lymphoid                  1 (20%)      2 (33%)                   1 (33%)                               
      Inguinal, Pigmentation                                                                  1 (33%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      15 MG/KG     50 MG/KG     150                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Mediastinal, Hemorrhage                          1 (20%)                                                                      
      Pancreatic, Hyperplasia, Lymphoid                             2 (33%)                                                         
      Renal, Hyperplasia                                            1 (17%)                                                         
   Lymph Node, Mandibular                             (42)         (47)         (47)         (47)                                   
      Hyperplasia, Histiocytic                         1 (2%)                                                                       
      Hyperplasia, Lymphoid                                                      1 (2%)       2 (4%)                                
      Necrosis                                                                                1 (2%)                                
   Lymph Node, Mesenteric                             (50)         (46)         (50)         (48)                                   
      Atrophy                                                                                 2 (4%)                                
      Ectasia                                          3 (6%)                    1 (2%)                                             
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hemorrhage                                      17 (34%)     13 (28%)      9 (18%)      6 (13%)                               
      Hyperplasia, Lymphoid                            1 (2%)                    3 (6%)       2 (4%)                                
      Pigmentation                                                  1 (2%)                                                          
   Spleen                                             (50)         (49)         (50)         (49)                                   
      Depletion Cellular                               1 (2%)                                12 (24%)                               
      Fibrosis, Focal                                  1 (2%)                                                                       
      Hematopoietic Cell Proliferation                20 (40%)     27 (55%)     25 (50%)     13 (27%)                               
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
   Thymus                                             (43)         (42)         (44)         (46)                                   
      Atrophy                                          2 (5%)       6 (14%)      4 (9%)       5 (11%)                               
      Cyst                                             6 (14%)      6 (14%)      5 (11%)      3 (7%)                                
      Necrosis                                                      1 (2%)       1 (2%)      11 (24%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic, Focal                                                            1 (2%)                                
      Dermis, Fibrosis                                              1 (2%)                                                          
      Epidermis, Hyperplasia, Focal                                              1 (2%)                                             
      Subcutaneous Tissue, Edema                       1 (2%)       2 (4%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Cranium, Hyperostosis                                         1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Necrosis                                         1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05067-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            THEOPHYLLINE                                       Date: 07/03/96  
Route: GAVAGE                                                                                                     Time: 13:10:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      15 MG/KG     50 MG/KG     150                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                                    1 (2%)                    4 (8%)                                
      Foreign Body                                                  1 (2%)                                                          
      Hemorrhage                                       3 (6%)       1 (2%)                    1 (2%)                                
      Hyperplasia, Histiocytic                         4 (8%)                    4 (8%)       1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 1 (2%)       2 (4%)       1 (2%)                                             
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                        1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Harderian Gland                                    (1)          (4)          (2)          (2)                                    
      Inflammation, Chronic, Focal                                  1 (25%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (49)         (50)         (50)                                   
      Congestion                                       1 (2%)                                 1 (2%)                                
      Cyst                                             2 (4%)                    1 (2%)       2 (4%)                                
      Infarct                                                                    2 (4%)       2 (4%)                                
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)       1 (2%)       1 (2%)                                             
      Metaplasia, Focal, Osseous                                    1 (2%)       2 (4%)       1 (2%)                                
      Nephropathy                                     46 (92%)     46 (94%)     45 (90%)     29 (58%)                               
      Papilla, Necrosis                                                          1 (2%)                                             
      Renal Tubule, Degeneration                                                              7 (14%)                               
      Renal Tubule, Dilatation                                                                4 (8%)                                
   Urethra                                            (3)          (3)          (1)                                                 
      Inflammation, Chronic                                         1 (33%)                                                         
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------